Qualitative Evaluation of Therapeutic Alliance in Adolescent Psychiatry
EVAADO
1 other identifier
observational
129
1 country
2
Brief Summary
Context: Psychiatric disorders (anorexia nervosa, depression, anxiety based school refusal) are a major public health concern in adolescence. Their treatment is a challenge for the families, the health care system and society. The treatment is complex and non-standardized. In clinical practice, the relational dimension between the stakeholders is recognized by all. Nevertheless no study has ever crossed their perspectives about therapeutic alliance in adolescent psychiatry. Objective: to explore, within a qualitative approach, how a therapeutic alliance is established in three different clinical situations according to the adolescents, their parents and their physicians by crossing their perspectives. Methods: This is a national (France) multi-center qualitative study based on 180 semi-structured interviews. Participants (purposively selected until data saturation) came from three different sub-samples: (i) adolescents with anorexia nervosa (N =20) plus their parents (N=20) and their physicians (N=20), (ii) adolescents with depressions (N=20) plus their parents (N=20) and their physicians (N=20), and (iii) adolescents with anxiety-based school refusal (N=20) plus their parents (N=20) and their physicians (N=20). Data are collected through open ended semi structured interviews and independently analyzed with NVivo V.11 software by three researchers according to the principles of Interpretative Phenomenological Analysis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2016
Longer than P75 for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2016
CompletedFirst Submitted
Initial submission to the registry
September 13, 2017
CompletedFirst Posted
Study publicly available on registry
September 20, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2021
CompletedAugust 23, 2024
August 1, 2024
4 years
September 13, 2017
August 22, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
to describe the facilitators of therapeutic alliance within adolescent psychiatry using a qualitative approach
qualitative methodology using verbal data analysis of semi-structured interviex
2 years
Study Arms (3)
Anorexia nervosa
adolescents with anorexia nervosa (N=20 ?), their parents (N=20), their physicians (N=20)
Anxiety based school refusal
adolescents with anxiety based school refusal (N=20 ?), their parents (N=20), their physicians (N=20)
Depression
adolescents with depression (N=20 ?), their parents (N=20), their physicians (N=20)
Eligibility Criteria
adolescents with psychiatric disorders
You may qualify if:
- adolescents, boys and girls, aged 12 to 18 years, speaking fluent French, with (i) anorexia nervosa according to DSM 5 criteria (ii) depressive disorders (dysthymia, depressive episode) according to DSM 5 criteria (iii) anxiety-based school refusal according to four criteria:
- refusal to attend school (to operationalize this first criterion, adolescents were included if they had not attended school at all for at least one month before starting treatment); (2) presence of a DSM-5 anxiety disorder (except obsessive-compulsive or post-traumatic stress disorders) with emotional upset at the prospect of attending school; (3) absence of a DSM-5 conduct disorder; and (4) parental knowledge of the adolescent's whereabouts during the period of non-attendance.
- that led to treatment that had begun at least six months earlier and clinically determined to be well enough to participate in a research interview.
- receiving treatment for at least 6 months
- one parent at least agrees to participate
You may not qualify if:
- acute symptoms and serious somatic and/or psychiatric co-morbidities
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
CHVictorDupouy
Argenteuil, 95100, France
CHU Rouen
Rouen, 76000, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Anne Revah-Levy, MD PhD
Paris diderot University
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Pr Anne Revah-Levy
Study Record Dates
First Submitted
September 13, 2017
First Posted
September 20, 2017
Study Start
January 1, 2016
Primary Completion
December 31, 2019
Study Completion
June 30, 2021
Last Updated
August 23, 2024
Record last verified: 2024-08
Data Sharing
- IPD Sharing
- Will not share